U.S. Aorto-iliac Occlusive Disease (Iliac Disease) Treatment Market (2025 - 2030) Size, Share & Trends Analysis Report By Device Type (Endovascular Devices, Surgical Devices), By Procedure, By End-use (Hospitals, Outpatient Facilities), And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Device Type
                        1.2.2. Procedure
                        1.2.3. End Use
                        1.2.4. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Volume price analysis (Model 1)
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Device Type outlook
                        2.2.2. Procedure outlook
                        2.2.3. End Use outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Rising prevalence of peripheral artery disease (PAD)
                            3.2.1.2. Advancements in endovascular technologies
                            3.2.1.3. Shift towards in minimally invasive procedures
                        3.2.2. Market restraint analysis
                            3.2.2.1. Product recalls
                            3.2.2.2. Clinical complexity and procedural risks
                    3.3. U.S. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. U.S. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Device Type Estimates & Trend Analysis
                    4.1. U.S. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Device Type Dashboard
                    4.2. U.S. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Device Type Movement Analysis
                    4.3. U.S. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market by Device Type, Revenue
                    4.4. Endovascular Devices
                        4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        4.4.2. Balloon Angioplasty Devices
                            4.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        4.4.3. Atherectomy Systems
                            4.4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        4.4.4. Stents
                            4.4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                            4.4.4.2. Self-expanding Stents
                                4.4.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                            4.4.4.3. Balloon-expandable Stents
                                4.4.4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                            4.4.4.4. Covered stent grafts
                                4.4.4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                            4.4.4.5. Bifurcated aortic stent grafts
                                4.4.4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                    4.5. Surgical Devices
                        4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. U.S. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Procedure Estimates & Trend Analysis
                    5.1. U.S. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Procedure Dashboard
                    5.2. U.S. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: Procedure Movement Analysis
                    5.3. U.S. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market by Procedure, Revenue
                    5.4. Endovascular Procedures
                        5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        5.4.2. Balloon Angioplasty
                            5.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        5.4.3. Primary Stenting
                            5.4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        5.4.4. Kissing Stents
                            5.4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        5.4.5. Covered Stent Grafts
                            5.4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                        5.4.6. Endovascular Aortic Repair (EVAR)
                            5.4.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                    5.5. Hybrid Procedures
                        5.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                    5.6. Surgical Procedures
                        5.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. U.S. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: End Use Estimates & Trend Analysis
                    6.1. U.S. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: End Use Dashboard
                    6.2. U.S. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market: End Use Movement Analysis
                    6.3. U.S. Aorto-Iliac Occlusive Disease (Iliac Disease) Treatment Market by End Use, Revenue
                    6.4. Hospitals
                        6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                    6.5. Outpatient Facilities
                        6.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
                    6.6. Others
                        6.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Manufacturers
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. Key company market share analysis, 2024
                    7.4. Company Profiles
                        7.4.1. BD
                            7.4.1.1. Company overview
                            7.4.1.2. Financial performance
                            7.4.1.3. Product benchmarking
                            7.4.1.4. Strategic initiatives
                        7.4.2. Abbott
                            7.4.2.1. Company overview
                            7.4.2.2. Financial performance
                            7.4.2.3. Product benchmarking
                            7.4.2.4. Strategic initiatives
                        7.4.3. Boston Scientific Corporation
                            7.4.3.1. Company overview
                            7.4.3.2. Financial performance
                            7.4.3.3. Product benchmarking
                            7.4.3.4. Strategic initiatives
                        7.4.4. W. L. Gore & Associates, Inc.
                            7.4.4.1. Company overview
                            7.4.4.2. Financial performance
                            7.4.4.3. Product benchmarking
                            7.4.4.4. Strategic initiatives
                        7.4.5. Medtronic
                            7.4.5.1. Company overview
                            7.4.5.2. Financial performance
                            7.4.5.3. Product benchmarking
                            7.4.5.4. Strategic initiatives
                        7.4.6. Cook
                            7.4.6.1. Company overview
                            7.4.6.2. Financial performance
                            7.4.6.3. Product benchmarking
                            7.4.6.4. Strategic initiatives
                        7.4.7. Terumo Corporation
                            7.4.7.1. Company overview
                            7.4.7.2. Financial performance
                            7.4.7.3. Product benchmarking
                            7.4.7.4. Strategic initiatives
                        7.4.8. Getinge AB
                            7.4.8.1. Company overview
                            7.4.8.2. Financial performance
                            7.4.8.3. Product benchmarking
                            7.4.8.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 List of secondary sources
Table 3 U.S. aorto-iliac occlusive disease (iliac disease) treatment market, by device type, 2018 - 2030 (USD Million)
Table 4 U.S. aorto-iliac occlusive disease (iliac disease) treatment market, by procedure, 2018 - 2030 (USD Million)
Table 5 U.S. aorto-iliac occlusive disease (iliac disease) treatment market, by end use, 2018 - 2030 (USD Million)
Table 6 Participant’s overview
Table 7 Financial performance
Table 8 Key companies undergoing expansions
Table 9 Key companies undergoing acquisitions
Table 10 Key companies undergoing collaborations
Table 11 Key companies launching new services
Table 12 Key companies undergoing partnerships
Table 13 Key companies undertaking other strategies 

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 U.S. aorto-iliac occlusive disease (iliac disease) treatment market segmentation
Fig. 7 Market snapshot, 2024
Fig. 8 Market trends & outlook
Fig. 9 Market driver relevance analysis (current & future impact)
Fig. 10 Market restraint relevance analysis (current & future impact)
Fig. 11 Swot analysis, by factor (political & legal, economic, and technological)
Fig. 12 Porter’s five forces analysis
Fig. 13 U.S. aorto-iliac occlusive disease (iliac disease) treatment market: Device Type Outlook Key Takeaways
Fig. 14 U.S. aorto-iliac occlusive disease (iliac disease) treatment market: Device Type Movement Analysis
Fig. 15 Endovascular devices market, 2018 - 2030 (USD Million)
Fig. 16 Balloon angioplasty devices market, 2018 - 2030 (USD Million)
Fig. 17 Atherectomy systems market, 2018 - 2030 (USD Million)
Fig. 18 Stents market, 2018 - 2030 (USD Million)
Fig. 19 Self-expanding stents market, 2018 - 2030 (USD Million)
Fig. 20 Balloon-expandable stents market, 2018 - 2030 (USD Million)
Fig. 21 Covered stent grafts market, 2018 - 2030 (USD Million)
Fig. 22 Bifurcated aortic stent grafts market, 2018 - 2030 (USD Million)
Fig. 23 Surgical devices market, 2018 - 2030 (USD Million)
Fig. 24 U.S. aorto-iliac occlusive disease (iliac disease) treatment market: Procedure outlook key takeaways
Fig. 25 U.S. aorto-iliac occlusive disease (iliac disease) treatment market: Procedure movement analysis
Fig. 26 Endovascular procedures market, 2018 - 2030 (USD Million)
Fig. 27 Balloon angioplasty market, 2018 - 2030 (USD Million)
Fig. 28 Primary stenting market, 2018 - 2030 (USD Million)
Fig. 29 Kissing stents market, 2018 - 2030 (USD Million)
Fig. 30 Covered stent grafts market, 2018 - 2030 (USD Million)
Fig. 31 Endovascular aortic repair (EVAR) market, 2018 - 2030 (USD Million)
Fig. 32 Hybrid procedures market, 2018 - 2030 (USD Million)
Fig. 33 Open surgical procedures market, 2018 - 2030 (USD Million)
Fig. 34 U.S. aorto-iliac occlusive disease (iliac disease) treatment market: End Use outlook key takeaways
Fig. 35 U.S. aorto-iliac occlusive disease (iliac disease) treatment market: End Use movement analysis
Fig. 36 Hospitals market, 2018 - 2030 (USD Million)
Fig. 37 Outpatient facilities market, 2018 - 2030 (USD Million)
Fig. 38 Others market, 2018 - 2030 (USD Million)
Fig. 39 Strategy framework